This scenario has been advocated as the case of DNMT3A-mutated NPM1-mutated AML [32] and is thought to model AML characterized by highly immature myeloperoxidase-negative nonlymphocytic blasts. Here, DNMT3A is linked to acute myeloid leukemia.